NCT06056011View on ClinicalTrials.gov

Timmy3 Module Clinical Accuracy ISO 80601-2-56:2017 + A1 2018

NAEnrolling by invitationINTERVENTIONAL
Enrollment

420

Participants

Timeline

Start Date

February 19, 2024

Primary Completion Date

May 30, 2025

Study Completion Date

September 30, 2025

Conditions
Febrile Illness
Interventions
DEVICE

Connex CSVM with Timmy3 module

Connex Vital Signs Monitor with the Timmy3 Investigational module

Trial Locations (5)

14203

John R. Oishei Children's Hospital, Buffalo

29425

Medical University of South Carolina, Charleston

30214

First Georgia Physicians Group, Fayetteville

56001

Mankato Clinic, Mankato

75230

Forest Lane Pediatrics, Dallas

All Listed Sponsors
lead

Baxter Healthcare Corporation

INDUSTRY

NCT06056011 - Timmy3 Module Clinical Accuracy ISO 80601-2-56:2017 + A1 2018 | Biotech Hunter | Biotech Hunter